Document is current
Any future updates will be listed below
-
Authors
Shturman, Isaac
Garzón, Hamilton
Coimbra, Daniel
Villafranca, Jorge
Zimbres, Silvia
de los Angeles Pyke, Maria
Van Der Graaff, Irina
Dabronzo, Maria Luiza
-
Funding
Funding for this research was provided by:
Allergan Aesthetics, an AbbVie Company
- License Information
-
More Information
Article History
Received: 2 December 2025
Accepted: 25 February 2026
First Online: 16 April 2026
Declarations
:
: Daniel Coimbra: Speaker, Allergan Aesthetics, an AbbVie Company. Hamilton Garzón: No conflicts to disclose. Isaac Shturman: Speaker and consultant for Allergan Aesthetics, an AbbVie Company. Jorge Villafranca: Speaker and consultant for Allergan Aesthetics, an AbbVie Company. Silvia Zimbres: Medical consultant and speaker for AbbVie/Allergan Aesthetics, an AbbVie Company, Johnson & Johnson/Kenvue, Neauvia, NAOS, and L’Oréal. Maria de los Angeles Pyke, Irina Van Der Graaff, and Maria Luiza Dabronzo: full-time employees of AbbVie and may own AbbVie stock.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: All participants give their informed consent in writing prior to inclusion in the study.
